665 related articles for article (PubMed ID: 12595913)
1. Moclobemide: therapeutic use and clinical studies.
Bonnet U
CNS Drug Rev; 2003; 9(1):97-140. PubMed ID: 12595913
[TBL] [Abstract][Full Text] [Related]
2. A risk-benefit assessment of moclobemide in the treatment of depressive disorders.
Norman TR; Burrows GD
Drug Saf; 1995 Jan; 12(1):46-54. PubMed ID: 7741983
[TBL] [Abstract][Full Text] [Related]
3. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
Foster RH; Goa KL
CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
[TBL] [Abstract][Full Text] [Related]
4. Moclobemide. An update of its pharmacological properties and therapeutic use.
Fulton B; Benfield P
Drugs; 1996 Sep; 52(3):450-74. PubMed ID: 8875133
[TBL] [Abstract][Full Text] [Related]
5. Tolerability of moclobemide, a new reversible inhibitor of monoamine oxidase-A, compared with other antidepressants and placebo.
Versiani M; Nardi AE; Figueira IL; Stabl M
Acta Psychiatr Scand Suppl; 1990; 360():24-8. PubMed ID: 2123366
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview.
Amrein R; Stabl M; Henauer S; Affolter E; Jonkanski I
Can J Psychiatry; 1997 Dec; 42(10):1043-50. PubMed ID: 9469236
[TBL] [Abstract][Full Text] [Related]
7. RIMA--a new concept in the treatment of depression with moclobemide.
Amrein R; Hetzel W; Stabl M; Schmid-Burgk W
Int Clin Psychopharmacol; 1993 Jan; 7(3-4):123-32. PubMed ID: 8468432
[TBL] [Abstract][Full Text] [Related]
8. Comparison of moclobemide with selective serotonin reuptake inhibitors (SSRIs) on sexual function in depressed adults. The Australian and German Study Groups.
Philipp M; Tiller JW; Baier D; Kohnen R
Eur Neuropsychopharmacol; 2000 Sep; 10(5):305-14. PubMed ID: 10974600
[TBL] [Abstract][Full Text] [Related]
9. RIMA: a safe concept in the treatment of depression with moclobemide.
Amrein R; Hetzel W; Stabl M; Schmid-Burgk W
Can J Psychiatry; 1992 Sep; 37 Suppl 1():7-11. PubMed ID: 1394030
[TBL] [Abstract][Full Text] [Related]
10. Moclobemide. A review of its pharmacological properties and therapeutic use in depressive illness.
Fitton A; Faulds D; Goa KL
Drugs; 1992 Apr; 43(4):561-96. PubMed ID: 1377119
[TBL] [Abstract][Full Text] [Related]
11. Review of comparative clinical trials. Moclobemide vs tricyclic antidepressants and vs placebo in depressive states.
Stabl M; Biziére K; Schmid-Burgk W; Amrein R
J Neural Transm Suppl; 1989; 28():77-89. PubMed ID: 2677244
[TBL] [Abstract][Full Text] [Related]
12. Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.
Kennedy SH; Eisfeld BS; Dickens SE; Bacchiochi JR; Bagby RM
J Clin Psychiatry; 2000 Apr; 61(4):276-81. PubMed ID: 10830148
[TBL] [Abstract][Full Text] [Related]
13. Switch in treatment from tricyclic antidepressants to moclobemide: a new generation monoamine oxidase inhibitor.
Dingemanse J; Kneer J; Fotteler B; Groen H; Peeters PA; Jonkman JH
J Clin Psychopharmacol; 1995 Feb; 15(1):41-8. PubMed ID: 7714227
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy of antidepressants.
Kasper S; Fuger J; Möller HJ
Drugs; 1992; 43 Suppl 2():11-22; discussion 22-3. PubMed ID: 1378369
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of antidepressants in agitated anxious depression--a meta-analysis of moclobemide studies.
Delini-Stula A; Mikkelsen H; Angst J
J Affect Disord; 1995 Oct; 35(1-2):21-30. PubMed ID: 8557884
[TBL] [Abstract][Full Text] [Related]
16. Reversible and selective inhibitors of monoamine oxidase A in mental and other disorders.
Priest RG; Gimbrett R; Roberts M; Steinert J
Acta Psychiatr Scand Suppl; 1995; 386():40-3. PubMed ID: 7717094
[TBL] [Abstract][Full Text] [Related]
17. Reversible and selective inhibitors of monoamine oxidase A in the treatment of depressed elderly patients.
Nair NP; Ahmed SK; Kin NM; West TE
Acta Psychiatr Scand Suppl; 1995; 386():28-35. PubMed ID: 7717092
[TBL] [Abstract][Full Text] [Related]
18. [Neurobiology and pharmacotherapy of social phobia].
Aouizerate B; Martin-Guehl C; Tignol J
Encephale; 2004; 30(4):301-13. PubMed ID: 15538306
[TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapy of dysthymic and chronic depressive disorders: overview with focus on moclobemide.
Versiani M
J Affect Disord; 1998 Dec; 51(3):323-32. PubMed ID: 10333986
[TBL] [Abstract][Full Text] [Related]
20. Mirtazapine : A Review of its Pharmacology and Therapeutic Potential in the Management of Major Depression.
Davis R; Wilde MI
CNS Drugs; 1996 May; 5(5):389-402. PubMed ID: 26071050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
